A two-fold ambition for Evolucare: international expansion and artificial intelligence
July 4, 2019
A two-fold ambition for Evolucare: international expansion and Artificial Intelligence. Supported by its new partner, Essling Expansion, Evolucare targets a robust growth both internally and externally. The company is relying on Artificial ...
Evolucare presents its new offer OphtAI at the 13th annual meeting of WAEH
June 5, 2019
Evolucare will present its new offer OphtAI at the 13th annual meeting of WAEH (The World Association of Eye Hospitals) organized in London (June, 5th-8th) by the prestigious Moorfields Eye Hospital.
Evolucare OphtAI – finalist of « HIT Innovations Trophées 2019 »
May 15, 2019
We are proud to announce that our new product Evolucare OphtAI is finalist of the « HIT Innovations Trophées 2019 », the innovation contest organized by Paris Healthcare Week
Official launch for OphtAI, a Joint-Venture dedicated to Artificial Intelligence for ophtalmology
May 13, 2019
Evolucare & its partner ADCIS, expert SME in applied image analysis for various fields including ophthalmology, chose the International Ophthalmology French Society (125th Edition, 11-14th of May 2019, at Paris Congresses Palace) to seal, ...
#OphtAI gets CE Medical Device Certification
April 4, 2019
#OphtAI, the new #AI product line of #Evolucare and #ADCIS, gets CE Medical Device Certification.
Our Artificial Intelligence, now available for clinical use, identifies diabetic retinopathy from a mere retina fundus image with performances ...
Signature of a global and exclusive licence agreement for the exploitation of OphtAI
January 30, 2019
At CES 2019, Evolucare, associated with ADCIS, enters into a global and exclusive license agreement with SATT Ouest Valorisation, a French technology transfer office, and AP-HP Paris hospitals for the exploitation of OphtAI
